Panel Discussion: Unlocking the Full Potential of Tissue-Free, Methylation-Based Liquid Biopsies to Redefine Monitoring
Time: 12:30 pm
day: Conference Day 1
Details:
- The logistical and clinical limitations of tissue-informed methods, including time to treatment, tissue availability, and turnaround time
- How methylation signatures may offer higher sensitivity and broader applicability than variant tracking alone
- Considerations for clinical validation, regulatory frameworks, and payer acceptance of tissue-free MRD solutions
